Delphi Ventures is a thesis-driven, high-conviction venture capital firm that allocates capital across core themes with a focus on life sciences. Founded over 30 years ago, it has helped several drugs achieve market approval and has enabled companies to expand therapeutic access for patients.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions